EVERY March 24, the world observes World Tuberculosis (TB) Day, which marks the 1882 discovery of the bacterium that causes the disease. More than a century later, tuberculosis remains one of the world’s deadliest infectious killers. In the Philippines, it continues to pose a stubborn — and often underrecognized — public health challenge.
In crowded communities across Metro Manila, mornings at local health centers often begin with patients enrolled in the Directly Observed Treatment, Short-course (DOTS) program lining up to take their daily medication under supervision. A construction worker arrives before his shift; a mother carrying a child pauses briefly to swallow tablets she must take for months to complete her treatment.
Across villages in the Bangsamoro Autonomous Region in Muslim Mindanao (BARMM), community health volunteers describe a similar routine. Traveling by motorcycle or on foot, they visit patients in scattered “sitios,” or hamlets — farmers, tricycle drivers, teenagers recovering from months of coughing — to ensure that each dose is taken and no treatment is missed.
These quiet routines form the front line of tuberculosis control in the Philippines.
The World Health Organization (WHO) says the Philippines remains among the countries with the highest TB burden globally. An estimated 739,000 Filipinos developed the disease in 2023 — more than 600 cases per 100,000 population. TB continues to claim tens of thousands of lives each year, making it one of the country’s most persistent infectious killers.
Equally troubling is the number of “missing TB cases.” While the Department of Health recorded more than 575,000 cases in 2023, epidemiological estimates suggest that many individuals remain undiagnosed, untreated, or outside official reporting systems.
Tuberculosis is often described as a disease of poverty, and the Philippine experience illustrates why. It spreads easily in overcrowded homes, poorly ventilated workplaces, and dense urban settlements where close contact allows the bacteria to circulate.
Nutrition plays a critical role. Undernutrition weakens the immune system, increasing vulnerability to infection and disease progression. At the same time, the rising prevalence of diabetes heightens the risk that latent TB infection — a dormant state of the bacteria — would develop into an active disease.
Recent economic pressures further complicate the picture. Rising fuel prices increase transportation costs for patients who must travel repeatedly to health centers. For households already struggling with daily expenses, even a short trip to the clinic becomes a burden.
National surveys also point to persistent hunger and food insecurity among Filipino families. Malnutrition, especially among the poor, creates conditions in which TB spreads more easily and recovery becomes more difficult.
Public health programs must also operate within broader governance constraints. Limited health budgets, uneven resource distribution, and recurring concerns about inefficiencies in public spending can weaken the reach of disease-control efforts.
Despite these challenges, important progress is underway.
The Philippines has expanded the use of rapid molecular diagnostic tests such as GeneXpert, which can detect TB bacteria and drug resistance within hours, instead of weeks. Health authorities are also deploying portable digital chest X-rays with artificial intelligence, enabling screening in communities where radiologists are unavailable.
Treatment has improved as well. Drug-resistant TB once required therapy lasting up to two years, often involving injections and severe side effects. Today, newer all-oral regimens can shorten treatment to six months, significantly improving patient outcomes.
The government’s National Tuberculosis Control Program remains the backbone of the response, aiming to expand screening, strengthen case detection, and ensure treatment completion through community-based approaches like the DOTS.
Financial protection has also expanded. The Philippine Health Insurance Corp. (PhilHealth) provides coverage through the TB-DOTS outpatient package and the Konsulta primary care program — now strengthened under PhilHealth Yakap (Yaman ng Kalusugan) — helping reduce financial barriers to diagnosis and treatment.
International partnerships, including with the Global Fund to Fight AIDS, Tuberculosis and Malaria and the WHO, continue to support these efforts.
Perhaps the most promising scientific development in decades is the emergence of a new tuberculosis vaccine candidate for adolescents and adults.
For more than a century, the BCG vaccine, developed in 1921, has been the only licensed TB vaccine. While effective in protecting children from severe forms of the disease, it provides limited protection against pulmonary TB in adults.
Researchers are now testing the M72/AS01E vaccine candidate in large Phase 3 trials across multiple sites in seven countries, involving around 20,000 participants, as reported by the WHO and its partners. Early studies suggest it could reduce progression from latent infection to active disease by about 50 percent.
If successful, such a vaccine could significantly reduce TB transmission in high-burden countries like the Philippines.
World TB Day reminds us that the fight against tuberculosis cannot rely on medicines alone. It requires better housing, stronger nutrition programs, accessible primary health care, and sustained investment in public health systems.
New technologies, improved treatments, and promising vaccines offer hope. Yet the daily work of health workers in crowded neighborhoods of Metro Manila and remote communities in the BARMM reminds us that the battle against TB unfolds one patient, one dose, and one community at a time.
Until the deeper conditions that allow tuberculosis to thrive — poverty, hunger, overcrowding, and fragile health systems — are confronted, the disease will remain more than a health problem. It will remain a measure of how far the country still has to go in building a society where health is truly shared by all.
